ImmunoSarc2: A Spanish Sarcoma Group (GEIS) Phase Ib Trial of Doxorubicin and Dacarbazine Plus Nivolumab in First Line Treatment of Advanced Leiomyosarcoma
JOURNAL OF CLINICAL ONCOLOGY(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2023)